Patent considerations in the immunotherapy space: Claiming by structure
In our previous articles, we discussed some general considerations that are likely important for Applicants seeking to obtain international patent protection for antibody inventions. These considerations, which concerned the requirements for support and enablement, as well as the requirements for inventive step focused primarily on Australia, the US and Europe as the main jurisdictions for […]
Inventive step considerations in the immunotherapy space
Following on from our previous article, which discussed some considerations for support and enablement of antibody inventions, our present article discusses the assessment of inventive step across the jurisdictions of Australia, Europe and the US, which relates closely to the criteria for support and enablement. Inventive step objections typically arise as a result of insufficient […]
Patent Considerations in the Immunotherapy Space: Support and Enablement
Market analytics reveals that the global antibody therapy market revenue is expected to surpass USD $450 billion by 2028, which by comparison is more than double that of the global market value of approximately USD $180 billion back in 2021. Such growth in the global market is driven predominantly by research in the therapeutic space, […]
A Guide to Plant Breeder’s Rights in Australia and New Zealand: Part 4
This article represents the final instalment of our 4-part series guide to Plant Breeder’s Rights (PBRs). In part 1 of the series, we discussed some general considerations that may be of interest to Applicants seeking to apply for PBRs in Australia and in New Zealand. This was followed by part 2, whereby we outlined the […]
A Guide to Plant Breeder’s Rights in Australia and New Zealand: Part 3
In part 1 of this guide, we outlined some basic considerations for Applicants who may be seeking to apply for Plant Breeder’s Rights (PBRs) in Australia and in New Zealand. Part 2 of this guide continued on from the above and provided information on how to navigate the application process for PBRs in Australia and […]
A Guide to Plant Breeder’s Rights in Australia and New Zealand: Part 2
Earlier in this article series, we discussed the basics behind Plant Breeder’s Rights (PBRs) and have discussed some considerations that should be taken into account when seeking to apply for PBRs in Australia and in New Zealand (A Guide to Plant Breeder’s Rights in Australia and New Zealand: Part 1 – Michael Buck I.P. (mbip.com.au)). […]
A Guide to Plant Breeder’s Rights in Australia and New Zealand: Part 1
Earlier this year, IP Australia launched a new Plant Breeder’s Rights (PBR) search aimed at making it easier to search for plant varieties, check status and ownership details, see what varieties look like, and download detailed descriptions. Considering this update to the IP Australia website and the significant effort that goes into the development of […]
Patent term extensions in Australia and beyond: Part 4
In this final instalment, we address common questions relating to requirements and rights during the (pharmaceutical) extension of term. You can follow these links to read part 1, part 2 and part 3. Can an extension of term be sought for patents containing a combination of pharmaceutical products? In Australia, the case of Merck Sharp […]
Patent term extensions in Australia and beyond: Part 3
Following on from our previous post in this series, in this article we look at the relevance of some major Australian cases, applications and appeals (referring to the Australian Register of Therapeutic Goods (ARTG) requirements) and by comparison, cases in the US and Europe. First regulatory approval i. Australia In Australia, where claims in a […]
Bioinformatics as a growing area of IP
Technological advances in science often involves being able to improve the way a task is carried out, whether the task can be done quicker, more conveniently and/or with more accuracy. In certain specialties of science, it is desirable to find ways to automate a task or to collate data from several sources to improve efficiency […]